scholarly journals Managing an adult CF population in the COVID-19 pandemic—1 year on

QJM ◽  
2021 ◽  
Author(s):  
D Nazareth ◽  
C Sumner ◽  
J Daniels ◽  
J Mathews ◽  
G Hyde ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Routine Care ◽  
Clinical Activity ◽  
Attendance Rates ◽  
Model Of Care ◽  
New Model ◽  
Video Assisted ◽  
Clinical Records ◽  
Multi Disciplinary Team ◽  
At Home

Summary Background The advent of the COVID-19 pandemic in 2020 required an alteration in the routine care of people with CF (pwCF), deemed to be extremely vulnerable. Aim We wished to report the alterations in clinical practice, including the introduction of remote video-assisted clinics, made to manage the adult pwCF attending our large centre. Methods We studied clinical records over a period of 2 years (March 2019 to February 2021) by comparing 19th March to 20th February (Y1) with 20th March to 21st February (Y2). Results We have shown out of hospital Multi Disciplinary Team (MDT) support increased and a greater proportion of IV therapy was administered at home. The VAC model of care increased clinical activity while reducing clinic non-attendance rates, suggesting more individuals engage with their carers. Conclusions This new model of care has allowed greater engagement with pwCF.

Rural palliative care to support dying at home can be realised; experiences of family members and nurses with a new model of care

2019 ◽  
Vol 27 (4) ◽  
pp. 336-343 ◽  
Author(s):  
Evelien Spelten ◽  
Jenny Timmis ◽  
Simone Heald ◽  
Saskia F. A. Duijts
Keyword(s):  
Palliative Care ◽  
Family Members ◽  
Model Of Care ◽  
New Model ◽  
Dying At Home ◽  
At Home

Physician Reentry into Clinical Practice: Regulatory Challenges

2011 ◽  
Vol 97 (1) ◽  
pp. 10-15 ◽  
Author(s):  
Gretchen P. Kenagy ◽  
Barbara S. Schneidman ◽  
Barbara Barzansky ◽  
Claudette E. Dalton ◽  
Carl A. Sirio ◽  
...  
Keyword(s):  
Clinical Practice ◽  
Empirical Studies ◽  
Clinical Activity ◽  
Central Importance ◽  
Regulatory Policies ◽  
Physician Competence ◽  
Leave Of Absence ◽  
Increasing Demand ◽  
State Medical Boards ◽  
Regulatory Challenges

ABSTRACT Physician reentry to clinical practice is fast becoming recognized as an issue of central importance in discussions about the physician workforce. While there are few empirical studies, existing data show that increasing numbers of physicians take a leave of absence from practice at some point during their careers; this trend is expected to continue. The process of returning to clinical practice is coming under scrutiny due to the public's increasing demand for transparency regarding physician competence. Criteria for medical licensure often do not include an expectation of ongoing clinical activity. Physicians who maintain a license but do not practice for a period of time, therefore, may be reentering the workforce with unknown competency to practice. This paper: (1) presents survey data on current physician reentry policies of state medical boards; (2) discusses the findings from the survey within the context of regulatory challenges that impact physician-reentry; and (3) offers recommendations to facilitate the development of comprehensive, coordinated regulatory policies on physician reentry.

A view on Practical Utility of Paradi Gunas

2017 ◽  
Vol 2 (2) ◽  
Author(s):  
Sachin Bagali ◽  
Umapati Baragi ◽  
M. R. Sajjanshetti
Keyword(s):  
Clinical Practice ◽  
Professional Practice ◽  
Continuous Process ◽  
Clinical Activity ◽  
Successful Management ◽  
Knowledge Domain ◽  
Practical Utility ◽  
The Subject ◽  
The Way

In the present day scenario prime need of Ayurveda is practical applicability of Ayurvedic fundamental principles and research should be more focused on all aspects where scientific inputs should confirm Ayurveda’s principles and philosophy. In Ayurveda, Gunas are described as the way of presentation of action without which no Karma (action) can be possible. Ayurveda has provided significance to every Guna so that they become useful in clinical practice. Clinical practice or research is a continuous process including a series of events which need to be performed in a sequential manner. Though there are many factors on which accomplishment of treatment depends, among these Charaka has given prime importance to Paradi Gunas. In clinical practice, Guna which are to be with Bhishak are mainly the Paradi Gunas which can also be called as miscellaneous Gunas. As rightly quoted by Acarya Charaka, for getting success in the treatment Paradi Gunas are the best. The Sutra quotes "Sidhyupaya Chikitsayam" which means that Chikitsa i.e. Dhatusamya will be done mainly with the help of Paradi Gunas. Knowledge of Paradi Gunas are required to be present in pharmacists, physicians and Researchers. Acharya Charaka says that Chikitsa Siddhi i.e. successful management of disease is not possible without the knowledge of Paradi Gunas. Paradi Gunas play an important role in selection, adaption and manifestation of drug as per condition of the disease and the patient in particular Desha and Kala. The ultimate goal of any clinical activity is to contribute in the knowledge domain and to improve professional practice. Thus this literary review of Paradi Gunas serves to explore the subject of the clinical practice.

scholarly journals Biomarkers in Hepatobiliary Cancers: What is Useful in Clinical Practice?

Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2708
Author(s):  
Alice Boilève ◽  
Marc Hilmi ◽  
Matthieu Delaye ◽  
Annemilaï Tijeras-Raballand ◽  
Cindy Neuzillet
Keyword(s):  
Clinical Practice ◽  
Single Agent ◽  
Survival Rates ◽  
Critical Evaluation ◽  
Treatment Modalities ◽  
Molecular Profile ◽  
Clinical Activity ◽  
Liver Malignancies ◽  
Antiangiogenic Drugs ◽  
Systemic Therapies

Hepatocellular carcinoma (HCC) and biliary tract cancers (BTC) exhibit a poor prognosis with 5-year overall survival rates around 15%, all stages combined. Most of these primary liver malignancies are metastatic at diagnostic, with only limited therapeutic options, relying mainly on systemic therapies. Treatment modalities are different yet partially overlapping between HCC and BTC. The complex molecular profile of BTC yields to several actionable therapeutic targets, contrary to HCC that remains the field of antiangiogenic drugs in non-molecularly selected patients. Immunotherapy is now validated in the first line in HCC in combination with bevacizumab, while clinical activity of single agent immunotherapy appears limited to a subset of patients in BTC, still poorly characterized, and combinations are currently under investigation. In this review, we provide a critical evaluation and grading of clinical relevance on (i) the main prognostic biomarkers in HCC and BTC, (ii) the main theragnostic biomarkers in both tumors, and lastly (iii) what is recommended in clinical practice.

341 Interdisciplinary counseling service for renal malignancies: Patients and physicians view of a new model of care

2013 ◽  
Vol 12 (1) ◽  
pp. e341
Author(s):  
J. Huber ◽  
A. Ihrig ◽  
E. Winkler ◽  
C. Gruellich ◽  
P. Hallscheidt ◽  
...  
Keyword(s):  
Counseling Service ◽  
Model Of Care ◽  
New Model ◽  
Renal Malignancies
Sign in / Sign up

Export Citation Format

Share Document